|
|
【MTOUCHE 0092 交流专区】万通科技
[复制链接]
|
|
|
发表于 15-3-2021 05:08 AM
|
显示全部楼层
| MTOUCHE TECHNOLOGY BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | ESOS | Details of corporate proposal | Exercise of ESOS | No. of shares issued under this corporate proposal | 25,082,803 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0550 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 1,164,983,559 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 143,395,810.975 | Listing Date | 23 Oct 2020 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 20-5-2021 07:41 AM
|
显示全部楼层
本帖最后由 icy97 于 16-9-2021 10:21 AM 编辑
icy97 发表于 25-5-2020 08:42 AM
NGS warrants that the Products sold hereunder shall be of merchantable quality and in accordance with any specifications which may be provided by NGS’s manufacturers and suppliers in the written or ...
Type | Announcement | Subject | OTHERS | Description | MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")PRESS RELEASE - SUPPLY AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND NETWORK GLOBAL SOLUTIONS PTY LTD | For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020.
Further to the Company’s announcement made on 14 April 2020 on the subject matter, the Board of Directors of mTouche is pleased to announce that the following Novel Coronavirus (SAR-CoV-2) RT-PCR Detection and Diagnostic Kit have been duly assessed and received final decision and approval by Medical Device Authority (MDA), under the purview of Ministry of Health Malaysia (MoH), and is now “Recommended for Use”:-
Manufacturers | Products Name | IVD Test Assay Evaluation By | LabGenomics Co., Ltd. (South Korea) | LabGun™ COVID-19 RT-PCR Kit | Institute for Medical Research, Malaysia (IMR) | Shanghai Fosun Long March Medical Science Co., Ltd (China) | Fosun COVID-19 RT-PCR Detection Kit | Institute for Medical Research, Malaysia (IMR) | Wuhan EasyDiagnosis Biomedicine Co., Ltd. (China) | COVID-19 (SARS-CoV-2) Nucleic Acid Test Kit | Makmal Kesihatan Awam Kebangsaan, Malaysia (MKAK) |
Please refer to the attached press release regarding the subject matter.
This announcement is dated 13 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3104800
Type | Announcement | Subject | OTHERS | Description | MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")DIGITAL DISTRIBUTION AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND MLABS RESEARCH SDN. BHD. | For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.
Further to the Company’s announcement made on 14 April 2020 and 13 November 2020, the Board of Directors of mTouche Technology Berhad (“MTOUCHE” or the “Company”) wishes to inform that mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the Company, had on 19 November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with Mlabs Research Sdn. Bhd. (“Mlabs Research”), to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through Mlabs digital distribution channel.
Mlabs Research is a wholly owned subsidiary of Mlabs Systems Berhad which the group is engaged in the investment holding, research and development in web conferencing and related products, provision of mobile application solution, online trading of white goods, film productions, and advisory services on digital assets and fintech investment.
The Agreement is to a period of one (1) year, commencing on and from 19 November 2020, unless otherwise mutually extended or terminated. Either party may terminate the Agreement upon delivery of written notice at least thirty (30) days prior to such termination.
The Agreement will not have any effects on the share capital and shareholding structure of the Company. However, it is expected to have positive contribution to the earnings and net assets of MTOUCHE Group.
Similar to all business entities, the risk factors affecting the execution of the Agreement, including but not limited to business risks such as prudent financial management, changes in political, economic and regulatory conditions. However, the Board will continue to exercise due care in considering the risks associated with the Agreement and will take appropriate measures in planning the successful execution of the Agreement.
The Agreement is not subject to the approval of the shareholders.
None of the Directors and/or other major shareholders of the Company and/or any persons connected to them have any interest, direct or indirect, in relation to the Agreement.
The Board, after due consideration, is of the opinion that the Agreement is in the best interest of the Group.
This announcement is dated 19 November 2020.
|
Type | Announcement | Subject | OTHERS | Description | MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")PRESS RELEASE - DIGITAL DISTRIBUTION AGREEMENT BETWEEN MTOUCHE INTERNATIONAL SDN. BHD. AND MLABS RESEARCH SDN. BHD. | For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.
Further to the Company’s announcement made on 14 April 2020 and 13 November 2020, the Board of Directors of mTouche Technology Berhad (“MTOUCHE” or the “Company”) wishes to announce that mTouche International Sdn. Bhd. (“MISB”), a wholly owned subsidiary of the Company, had on 19 November 2020 entered into a Digital Distribution Agreement (the “Agreement”) with Mlabs Research Sdn. Bhd. (“Mlabs Research”), to promote, market, and distribute Novel Coronavirus (SAR-CoV-2) RP-PCR Detection and Diagnostic kit and Novel Coronavirus (SAR-CoV-2) lgM/lgG Rapid Test Kit, and other equivalent products in Malaysia through Mlabs digital distribution channel.
Please refer to the attached press release regarding the subject matter.
This announcement is dated 19 November 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3106548
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2020 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 30 Sep 2020 | 30 Sep 2019 | 30 Sep 2020 | 30 Sep 2019 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 1,206 | 4,613 | 1,206 | 4,613 | | 2 | Profit/(loss) before tax | -1,017 | 616 | -1,017 | 616 | | 3 | Profit/(loss) for the period | -1,017 | 1,437 | -1,017 | 1,437 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -804 | 1,596 | -804 | 1,596 | | 5 | Basic earnings/(loss) per share (Subunit) | -0.08 | 0.31 | -0.11 | 0.31 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.0751 | 0.0863
|
Type | Announcement | Subject | OTHERS | Description | MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR "THE COMPANY")- MEDICAL DEVICE AUTHORITY ("MDA"), MALAYSIA QUERY AND CLARIFICATION | For consistency purposes, the abbreviations and definitions used throughout this announcement shall have the same meanings as those previously defined in the Company’s announcements dated 14 April 2020 and 13 November 2020.
Further to the Company’s announcements made on 14 April 2020 and 13 November 2020 pertaining to the Novel Coronovirus (SAR-Cov-2) RT-PCR Detection and Diagnostic Kit (COVID-19 Test Kits) have received the MDA’s “Recommended for Use”, with recent query and clarification received from the MDA on 23 November 2020, the Board of the Directors of the Company wishes to clarify and correct the following misstatement.
Under the MDA’s Special Access, no promotional and advertising activities is allowed without prior approval from the MDA. Chapter 9.12(1) of the ACE Market Listing Requirements (“ACE LR”) provides that a listed corporation must refrain from promotional disclosure activity in any form whatsoever or howsoever which may mislead investors or cause unwarranted price movement and activity in a listed corporation’s securities.
The Company wishes to clarify and confirm that the announcement made by the Company on 13 November 2020 is a continuing disclosure pursuant to Chapter 9.02(2)(a) of the ACE LR and the Company does not have any intention or motivation on any promotional related activities.
Besides, please be informed that the Company does not possess the MDA’s Establishment License and Good Distribution Practice for Medical Devices (GDPMD) currently. The Company is collaborating with Premier Diagnostics Sdn. Bhd. who holds the MDA’s Establishment License to apply for the Special Access from the MDA.
With further clarification received from the MDA, the Company is not allowed to “promote, market, distribute” as well as import any of the “Recommended for Use” COVID-19 Test Kits as the Company is not the registered holder for MDA’s Establishment License. Hence, the Company will continue to collaborate with its partner, Premier Diagnostics Sdn. Bhd. for the importation, warehousing and logistic support and the Company may collaborate with other MDA’s Establishment License Distributors for the distribution of the COVID-19 Test Kits.
This announcement is dated 1 December 2020. |
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | PROPOSED PRIVATE PLACEMENT | On behalf of the Board of Directors of the Company, Mercury Securities Sdn Bhd wishes to announce that the Company proposes to undertake a private placement of up to 116,498,000 new ordinary shares in the Company, representing approximately 10% of the existing total number of issued shares of the Company (excluding treasury shares) to independent third party investor(s) to be identified later and at an issue price to be determined later (“Proposed Private Placement”).
Please refer to the attachment for further details on the Proposed Private Placement.
This announcement is dated 18 December 2020. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3115377
Type | Announcement | Subject | NEW ISSUE OF SECURITIES (CHAPTER 6 OF LISTING REQUIREMENTS)
FUND RAISING | Description | MTOUCHE TECHNOLOGY BERHAD ("MTOUCHE" OR THE "COMPANY")PROPOSED PRIVATE PLACEMENT | (For consistency, the abbreviations used throughout this announcement shall have the same meanings as defined in the announcement dated 18 December 2020 in relation to the Proposed Private Placement, where applicable, unless stated otherwise or defined herein.)
Reference is made to the announcement dated 18 December 2020 in relation to the Proposed Private Placement (“First Announcement”).
On behalf of the Board, Mercury Securities wishes to furnish additional information in furtherance to the First Announcement.
Please refer to the attachment for further details on the additional information.
This announcement is dated 11 January 2021. |
https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3119983
| MTOUCHE TECHNOLOGY BERHAD |
| 1. Details of Corporate Proposal | Involve issuance of new type/class of securities ? | No | Types of corporate proposal | Private Placement | Details of corporate proposal | Private Placement of up to 10% of the total number of issued shares of the Company | No. of shares issued under this corporate proposal | 116,498,000 | Issue price per share ($$) | Malaysian Ringgit (MYR) 0.0618 | Par Value($$) (if applicable) |
| | Latest issued share capital after the above corporate proposal in the following | Units | 1,281,482,358 | Issued Share Capital ($$) | Malaysian Ringgit (MYR) 150,595,547.175 | Listing Date | 15 Jan 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 10-10-2021 09:28 AM
|
显示全部楼层
Notice of Interest Sub. S-hldr (Section 137 of CA 2016)| MTOUCHE TECHNOLOGY BERHAD |
Particulars of Substantial Securities HolderName | DGB NETWORKS SDN. BHD. | Address | Third Floor, No. 77, 79 & 81
Jalan SS21/60, Damansara Utama
Petaling Jaya
47400 Selangor
Malaysia. | Company No. | 201801012992 (1275008-T) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares | Name of registered holder | M&A Nominee (Tempatan) Sdn. Bhd. Sanston Financial Group Limited for DGB Networks Sdn. Bhd. | Address of registered holder | 45-1 & 47-1, Boulevard Mid Valley CityLingkaran Syed Putra59200 Kuala Lumpur |
| Date interest acquired & no of securities acquired | Date interest acquired | 06 Oct 2021 | No of securities | 48,751,000 | Circumstances by reason of which Securities Holder has interest | Acquisition of shares via open market | Nature of interest | Direct Interest |  | | Total no of securities after change | Direct (units) | 48,751,000 | Direct (%) | 5.261 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Date of notice | 08 Oct 2021 | Date notice received by Listed Issuer | 08 Oct 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 23-10-2021 11:47 AM
|
显示全部楼层
| MTOUCHE TECHNOLOGY BERHAD |
Particulars of substantial Securities HolderName | DGB NETWORKS SDN. BHD. | Address | THIRD FLOOR, NO. 77, 79 & 81
JALAN SS21/60
DAMANSARA UTAMA
PETALING JAYA
47400 Selangor
Malaysia. | Company No. | 201801012992 (1275008-T) | Nationality/Country of incorporation | Malaysia | Descriptions (Class) | Ordinary Shares |
Details of changesNo | Date of change | No of securities | Type of Transaction | Nature of Interest | | 1 | 21 Oct 2021 | 28,000,000 | Acquired | Direct Interest | Name of registered holder | DGB Networks Sdn. Bhd. | Address of registered holder | Third Floor, No. 77, 79 & 81 Jalan SS21/60, Damansara Utama 47400 Petaling Jaya Selangor | Description of "Others" Type of Transaction | |
Circumstances by reason of which change has occurred | Acquisition of shares via open market | Nature of interest | Direct Interest | Direct (units) | 79,751,000 | Direct (%) | 8.606 | Indirect/deemed interest (units) | 0 | Indirect/deemed interest (%) | 0 | Total no of securities after change | 79,751,000 | Date of notice | 22 Oct 2021 | Date notice received by Listed Issuer | 22 Oct 2021 |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 5-1-2022 09:41 AM
|
显示全部楼层
| MTOUCHE TECHNOLOGY BERHAD |
Date of change | 22 Nov 2021 | Name | YM RAJA HIZAD BIN RAJA KAMARULZAMAN | Age | 67 | Gender | Male | Nationality | Malaysia | Designation | Non Executive Chairman | Directorate | Independent and Non Executive | Type of change | Demised |
|
|
|
|
|
|
|
|
|
|
|
|
发表于 7-2-2022 10:45 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
30 Sep 2021 |
| | INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | Three Months | Three Months | Fifteen Months | Fifteen Months | 01 Jul 2021
To | 01 Jul 2020
To | 01 Jul 2020
To | 01 Jul 2019
To | 30 Sep 2021 | 30 Sep 2020 | 30 Sep 2021 | 30 Sep 2021 | $$'000 | $$'000 | $$'000 | $$'000 |
| 1 | Revenue | 14,619 | 1,206 | 18,727 | 0 | | 2 | Profit/(loss) before tax | -10,547 | -1,017 | -22,439 | 0 | | 3 | Profit/(loss) for the period | -10,144 | -1,017 | -22,036 | 0 | | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | -10,126 | -804 | -22,060 | 0 | | 5 | Basic earnings/(loss) per share (Subunit) | -1.09 | -0.08 | -2.17 | 0.00 | | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1708 | 0.0863
|
|
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
3962 
65
